Mometasone in Tanzania: NEMLIT level, who can prescribe it and STG references
Mometasone is on Tanzania's National Essential Medicines List (NEMLIT, 7th edition, 2026) at level S (zonal, special and national hospitals). It is not on the DukaDawa pharmacy network yet, so we show no brands or prices for it. The Standard Treatment Guidelines mention it in 8 or more sections.
Last updated
New to DukadawaRx? Register as a prescriber. Licensed prescribers only; we verify your registration before you can prescribe.
Is mometasone available on the DukaDawa pharmacy network?
Not yet. Mometasone is not in the DukaDawa network catalogue, so we have no brands, prices or stock for it.
Prescribers can still write it on a DukadawaRx prescription, and we show it here as soon as a network pharmacy lists it.
Is mometasone on the NEMLIT, and who can prescribe it?
Yes. Mometasone is on Tanzania's National Essential Medicines List (NEMLIT, 7th edition, 2026) at level S (zonal, special and national hospitals). At level S it may be prescribed by specialists.
- Level
- S (zonal, special and national hospitals)
- Category
- Anti-inflammatory and Anti-pruritic Medicines (Dermatological Medicines)
- Listed forms
- Ointment/Cream: 0.1% (as furoate); Nasal spray 50 micrograms/dose (as furoate)
- Page
- NEMLIT, p. 21
| Level | Facility | Who may prescribe |
|---|---|---|
| A | Dispensary | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer, Assistant Clinical Officer |
| B | Health centre | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer |
| C | Council or district hospital | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer |
| D | Regional referral hospital | Specialist, Medical Officer, Dental Officer |
| S (listed) | Zonal, special and national hospitals | Specialist |
A medicine is listed from the lowest facility level where it should be available.
Where is mometasone in the Standard Treatment Guidelines?
The Standard Treatment Guidelines (7th edition, 2026) mention mometasone in 8 or more sections, most often section 9.4.1.1 Obstructive Lung Diseases > Asthma > Management of Chronic Asthma (p. 210). See the STG for treatment details.
- 9.4.1.1 Obstructive Lung Diseases > Asthma > Management of Chronic Asthma, p. 210
- 15.4.3 Nose/Paranasal Sinuses Conditions > Allergic Rhinitis, p. 378
- 13.5.1 Eczema (Dermatitis) > Atopic Eczema (Dermatitis), p. 321
- 13.5.2 Eczema (Dermatitis) > Contact Eczema (Dermatitis), p. 323
- 13.11.1 Pigmentary Disorders > Vitiligo, p. 328
- 15.2.7.4 Trauma of the Pinna > Otitis Media (Acute or Chronic) > Otitis Media with Effusion (Glue Ear), p. 373
- 15.4.2 Nose/Paranasal Sinuses Conditions > Acute Non-Allergic Rhinitis, p. 378
- 15.6.6 Other Conditions of the Nose > Acute Rhinosinusitis, p. 383
Sections that mention Mometasone, most mentions first. Positions only: see the STG for treatment details.
Related medicines
- BetamethasoneNEMLIT C, D · Not on the DukaDawa network yet
- CalamineNEMLIT A · Not on the DukaDawa network yet
- Clobetasol propionateNEMLIT D · Not on the DukaDawa network yet
- FludrocortisoneNEMLIT D · Not on the DukaDawa network yet
- SulfurNEMLIT A · Not on the DukaDawa network yet
- TriamcinoloneNEMLIT C, S · Not on the DukaDawa network yet
All anti-inflammatory and anti-pruritic medicines on the NEMLIT
Sources
- Standard Treatment Guidelines and National Essential Medicines List (STG/NEMLIT), 7th edition, 2026, Ministry of Health, United Republic of Tanzania
Page last updated
STG positions are section numbers and printed page numbers only.
This page supports licensed prescribers and pharmacists. It is not medical advice and does not replace the Standard Treatment Guidelines, the product information or professional judgement. Prices and stock change often: confirm with the pharmacy.